The valuation for bio stocks are hard.
IVX & RAP, fetched $300m.
BIT, potential HIV cure drug. Gilead's one HIV inhibitor drug achieved annual revenue of US$3.5b.
You can see how the market is excite about BIT225, kill HIV viruses.
Ann: Biotron Secures $4.7 Million Underwriting Agreement, page-108
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $13.60K | 713.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1354305 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 112253 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |